• 1
    Castaman, G. & Rodeghiero, F. (1996) Desmopressin and type IIB von Willebrand disease. Haemophilia, 2, 7375.
  • 2
    Castillo, R., Escolar, G., Monteagudo, J., Aznar-Salatti, J., Reverter, J.C., Ordinas, A. (1997) Hemostasis in patients with severe von Willebrand disease improves after normal platelet transfusion and normalizes with further correction of the plasma defect. Transfusion, 37, 785790.
  • 3
    Castillo, R., Monteagudo, J., Escolar, G., Ordinas, A., Magallon, M., Martin Villar, J. (1991) Hemostatic effect of normal platelet transfusion in severe von Willebrand disease. Blood, 77, 19011905.
  • 4
    Chang, A.C., Jacobs, H., Weinstein, M.J., Kessler, C.M. (1998) The correlation of closure time and von Willebrand factor activity of factor VIII concentrates. Blood, 92, 3, 184a.
  • 5
    Fressinaud, E., Federici, A.B., Castaman, G., Rothschild, C., Rodeghiero, F., Baumgartner, H.R., Mannucci, P.M., Meyer, D. (1994) The role of platelet von Willebrand factor in platelet adhesion and thrombus formation: a study of 34 patients with various subtypes of type I von Willebrand disease. British Journal of Haematology, 86, 327332.
  • 6
    Fressinaud, E., Veyradier, A., Truchaud, F., Martin, I., Boyer-Neumann, C., Trossaert, M., Meyer, D. (1998) Screening for von Willebrand disease with a new analyzer utilizing high shear stress: a study of 60 cases. Blood, 91, 13251331.
  • 7
    Gralnick, H.R., Rick, M.E., McKeown, L.P., Williams, S.B., Parker, R.I., Maisonneuve, P., Jeanneau, C., Sultan, Y. (1986) Platelet von Willebrand factor: an important determinant of the bleeding time in type I von Willebrand's disease. Blood, 68, 5861.
  • 8
    Kundu, S.K., Heilmann, E., Sio, R., Garcia, C., Ostgaart, R. (1996) Characterization of an in vitro platelet function analyzer, PFA-100TM. Clinical and Applied Thrombosis/Hemostasis, 2, 241249.
  • 9
    Lyons, S.E., Bruck, M.E., Bowie, E.J.W., Ginsburg, D. (1992) Impaired intracellular transport produced by a subset of type IIA von Willebrand disease mutations. Journal of Biological Chemistry, 267, 44244430.
  • 10
    Mannucci, P.M. (1995) Platelet von Willebrand factor in inherited and acquired bleeding disorders. Proceedings of the National Academy of Sciences of the United States of America, 92, 24282432.
  • 11
    Mannucci, P.M. (1997) Desmopressin (DDAVP) in the treatment of bleeding disorders: the first 20 years. Blood, 90, 25152521.
  • 12
    Mannucci, P.M., Lattuada, A., Ruggeri, Z.M. (1994) Proteolysis of von Willebrand factor in therapeutic plasma concentrates. Blood, 83, 30183027.
  • 13
    Mannucci, P.M., Lombardi, R., Bader, R., Vianello, L., Federici, A.S., Solinas, S., Mazzucconi, M.G., Mariani, G. (1985) Heterogeneity of type I von Willebrand disease: evidence for a subgroup with an abnormal von Willebrand factor. Blood, 66, 796802.
  • 14
    Mannucci, P.M., Ruggeri, Z.M., Pareti, F.I., Capitanio, A. (1977) 1-Deamino-8-d arginine vasopressine: a new pharmacological approach to the management of haemophilia and von Willebrand's diseases. Lancet, i, 869872.DOI: 10.1016/S0140-6736(77)91197-7
  • 15
    Mannucci, P.M., Tenconi, P.M., Castaman, G., Rodeghiero, F. (1992) Comparison of four virus-inactivated plasma concentrates for treatment of severe von Willebrand disease: a cross-over randomized trial. Blood, 79, 31303137.
  • 16
    Meyer, D., Fressinaud, E., Gaucher, C., Lavergne, J.M., Hilbert, L., Ribba, A.S., Jorieux, S., Mazurier, C., and the INSERM Network on molecular abnormalities in von Willebrand disease (1997) Gene defects in 150 unrelated French cases with type 2 von Willebrand disease: from the patient to the gene. Thrombosis and Haemostasis, 78, 451456.
  • 17
    Meyer, D., Obert, B., Piétu, G., Lavergne, J.M., & Zimmerman, T.S. (1980) Multimeric structure of factor VIII/von Willebrand factor in von Willebrand's disease. Journal of Laboratory and Clinical Medicine, 95, 590602.
  • 18
    Nichols, W.C. & Ginsburg, D. (1997) von Willebrand disease. Reviews in Molecular Medicine, 76, 120.DOI: 10.1007/s001090050183
  • 19
    Rabinowitz, I., Tuley, E.A., Mancuso, D.J., Randi, A.M., Firkin, B.G., Howard, M.A., Sadler, J.E. (1992) von Willebrand disease type B: a missense mutation selectively abolishes ristocetin-induced von Willebrand factor binding to platelet glycoprotein Ib. Proceedings of the National Academy of Sciences of the United States of America, 89, 98469849.
  • 20
    Rodeghiero, F., Castaman, G., Dini, E. (1987) Epidemiological investigation of the prevalence of von Willebrand's disease. Blood, 69, 454459.
  • 21
    Rodeghiero, F., Castaman, G., Meyer, D., Mannucci, P.M. (1992) Replacement therapy with virus-inactivated plasma concentrates in von Willebrand disease. Vox Sanguinis, 62, 193199.
  • 22
    Sadler, J.E. (1994) A revised classification of von Willebrand disease. Thrombosis and Haemostasis, 71, 520525.